View Press Releases
-
ZEISS Crossbeam 550 sets new standards in 3D analytics and sample preparation with FIB-SEMs
JENA, GERMANY - May 9, 2017 - ZEISS presents a new generation of focused ion beam scanning electron microscopes (FIB-SEMs) for high-end applications in research and industry
May 9, 2017
-
Sekisui XenoTech Awarded Cryopreservation Patent
KANSAS CITY, KS, UNITED STATES - May 9, 2017 - Sekisui XenoTech was issued U.S. Patent No. 9,642,355 for the cryopreservation of cells and subcellular fractions, specifically related to Sekisui XenoTechs CryostaX® test systems, which are the only single-freeze pooled hepatocyte products in the industry
May 9, 2017
-
Optibrium and Goldfinch Bio Sign Agreement for StarDrop License
CAMBRIDGE, UK - May 9, 2017 - Optibrium, a developer of software for small molecule discovery, and Goldfinch Bio, a company focused on discovering and developing precision therapies to treat patients with kidney disease, today announced that the company has signed a multi-year agreement to license Optibriums StarDrop software
May 9, 2017
-
KCR Expands Its Presence in the U.S. Market
BERLIN, GERMANY - May 9, 2017 - KCR, a full service contract research organization, has announced today that it will be moving to a new office in Boston, MA, United States
May 9, 2017
-
BC Platforms Closes USD $10 million Series B Financing to accelerate knowledge platform development
BASEL, SWITZERLAND - May 9, 2017 - BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round
May 8, 2017
-
Precision NanoSystems @ CLINAM 2017
VANCOUVER, BC, CANADA - May 5, 2017 - Precision NanoSystems will be showcasing the benefits of its NanoAssemblr™ System and microfluidics technologies on booth #6 at this year's European Foundation of Clinical Nanomedicine (CLINAM) conference and exhibition
May 5, 2017
-
TraceLink Reports Highest Quarterly Revenue and Record-Breaking Growth in EMEA New Sales Bookings for Q1 2017
NORTH READING, MA - May 4, 2017 - North Reading, MA (May 4, 2017)-TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced financial and company results for the first quarter of 2017
May 4, 2017
-
RowAnalytics launches public beta of spot.my, its new deep semantic search tool for life science research
OXFORD, UNITED KINGDOM - May 4, 2017 - Complex data analytics software provider RowAnalytics Ltd today announced the beta release of spot.my, its powerful new search platform for open access life science literature
May 4, 2017
-
Apply AI to De-Risk Drug Discovery & Development
BOSTON, MA - May 8, 2017 - Unsustainable - The one word frequently used to describe traditional R&D. However, AI technologies are going to change that
May 4, 2017
-
GenSight Biologics Appoints Mohamed Genead as Chief Medical Officer
PARIS, FRANCE - May 3, 2017 - GenSight Biologics S.A. (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system, announced it has appointed Mohamed Genead, M
May 3, 2017
-
MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy
BAR HARBOR, ME, UNITED STATES - Apr 28, 2017 - The MDI Biological Laboratory has announced that Sandra Rieger, Ph.D., has been awarded a highly competitive grant from the National Cancer Institute, an institute of the National Institutes of Health (NIH), to study the molecular mechanisms underlying chemotherapy-induced peripheral neuropathy, a side effect of cancer chemotherapy causing symptoms such as pain, tingling, temperature sensitivity and numbness in the extremities
Apr 28, 2017
-
Joel Graber, Ph.D., Joins MDI Biological Laboratory As Senior Staff Scientist
BAR HARBOR, ME, UNITED STATES - Apr 28, 2017 - The MDI Biological Laboratory has announced that Joel Graber, Ph.D., will join the faculty as a senior staff scientist as of May 2
Apr 28, 2017
-
Rgenix Appoints Chief Medical Officer
NEW YORK, NY - Apr 27, 2017 - For Immediate ReleaseRgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today the appointment of Roger Waltzman, M
Apr 27, 2017
-
Record growth for life science tech firm as MES adoption increases globally
- Apr 27, 2017 - A global life science technology firm has surpassed the €20 million milestone for sales of its manufacturing execution system (MES) services
Apr 27, 2017
-
Concept Life Sciences further expands its service offering by investing in Micro Chamber and Thermal Extraction Facilities
MANCHESTER, UNITED KINGDOM - Apr 26, 2017 - Concept Life Sciences has further expanded its analytical testing capabilities by making significant investment into Micro Chamber and Thermal Extraction facilities, used to sample VOCs or SVOCs emitted from products and materials
Apr 26, 2017
-
MR Solutions wins second Queen’s Award for Enterprise
GUILDFORD, UNITED KINGDOM - Apr 26, 2017 - MR Solutions, of Guildford has won the prestigious Queens Award for Enterprise for International Trade
Apr 26, 2017
-
Future of Surfactants Summit North America
CHICAGO, IL - Sep 27, 2017 - Future of Surfactants Summit North America, 27th & 28th September 2017, Chicago, ILThe Impact of Evolving Trends, Environmental Standards &Consumer Preferences on the Demand of Specialty Surfactants
Apr 26, 2017
Following the success of our two European editions and inaugural North American version last year, we are pleased to announce the 2nd edition of our Future of Surfactants Summit North America will take place on the 27th & 28th September 2017, in Chicago, IL
-
Recipharm appoints Henrik Stenqvist as new Chief Financial Officer
STOCKHOLM, SWEDEN - Apr 11, 2017 - Recipharm AB today announced the appointment of Henrik Stenqvist as Recipharms new Executive Vice President and Chief Financial Officer, effective on April 24, 2017
Apr 25, 2017
-
Recipharm opens new GMP suite for clinical trial material
NORTH CAROLINA, NC - Apr 24, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina, USA
Apr 24, 2017
-
Recipharm delivers first serialised batch to Saudi Arabia
LISBON, PORTUGAL - Apr 21, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has delivered its first batch of serialised drug products to Saudi Arabia, following the introduction of new regulatory requirements in March 2017
Apr 21, 2017